Arno Therapeutics, Inc Shareholders' Equity
Arno Therapeutics, Inc had Shareholders' Equity of -$5.71 million as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2016-11-14
- 2016-09-30: Stockholders' Equity Attributable to Parent -$5.71M.
- 2016-06-30: Stockholders' Equity Attributable to Parent -$5.22M.
- 2016-03-31: Stockholders' Equity Attributable to Parent -$4.02M.
- 2015-12-31: Stockholders' Equity Attributable to Parent -$8.62M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2016-09-30 | -$5.71M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$5.22M 10-Q · filed 2016-08-22 |
| 2016-03-31 | -$4.02M 10-Q · filed 2016-05-16 |
| 2015-12-31 | -$8.62M 10-Q · filed 2016-11-14 |
| 2015-09-30 | -$5.24M 10-Q · filed 2015-11-16 |
| 2015-06-30 | -$5.50M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$3.01M 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$588.89K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$6.17M 10-Q · filed 2014-11-14 |
| 2014-06-30 | -$7.42M 10-Q · filed 2014-08-14 |
| 2014-03-31 | -$12.16M 10-Q · filed 2014-05-15 |
| 2013-12-31 | -$12.88M 10-K · filed 2016-03-30 |
| 2013-09-30 | -$26.33M 10-Q · filed 2013-11-14 |
| 2013-06-30 | -$22.88M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$12.44M 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$12.27M 10-K · filed 2015-03-31 |
| 2012-09-30 | -$3.93M 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$1.10M 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | -$1.05M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.36M 10-Q · filed 2014-08-14 |
| 2011-09-30 | $3.06M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $4.62M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $8.44M 10-Q · filed 2014-08-14 |
| 2009-12-31 | $1.58M 10-K · filed 2014-03-31 |
| 2008-12-31 | $7.86M 10-K · filed 2014-03-31 |
| 2007-12-31 | -$3.63M 10-K · filed 2014-03-31 |
| 2006-12-31 | -$356.19K 10-K · filed 2014-03-31 |
| 2005-07-31 | $0.00 10-Q · filed 2014-08-14 |